BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 147 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $574,000 | -14.1% | 185,100 | 0.0% | 0.00% | – |
| Q3 2021 | $668,000 | -3.0% | 185,100 | -3.8% | 0.00% | – |
| Q2 2021 | $689,000 | -8.4% | 192,400 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $752,000 | -6.9% | 192,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $808,000 | +12.5% | 192,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $718,000 | -10.8% | 192,400 | +4.2% | 0.00% | 0.0% |
| Q2 2020 | $805,000 | +35.3% | 184,700 | +17.7% | 0.00% | 0.0% |
| Q1 2020 | $595,000 | -39.0% | 156,900 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $975,000 | +277.9% | 154,300 | +86.8% | 0.00% | – |
| Q1 2016 | $258,000 | -18.6% | 82,600 | +24.8% | 0.00% | -100.0% |
| Q4 2015 | $317,000 | -13.9% | 66,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $368,000 | -18.8% | 66,200 | +16.3% | 0.00% | 0.0% |
| Q2 2015 | $453,000 | -19.7% | 56,900 | +6.0% | 0.00% | -50.0% |
| Q1 2015 | $564,000 | -9.0% | 53,700 | +4.1% | 0.00% | 0.0% |
| Q4 2014 | $620,000 | – | 51,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |